1. Home
  2. GTE vs NKTR Comparison

GTE vs NKTR Comparison

Compare GTE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTE
  • NKTR
  • Stock Information
  • Founded
  • GTE 2003
  • NKTR 1990
  • Country
  • GTE Canada
  • NKTR United States
  • Employees
  • GTE N/A
  • NKTR N/A
  • Industry
  • GTE Oil & Gas Production
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GTE Energy
  • NKTR Health Care
  • Exchange
  • GTE Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • GTE 183.8M
  • NKTR 160.4M
  • IPO Year
  • GTE N/A
  • NKTR 1994
  • Fundamental
  • Price
  • GTE $4.73
  • NKTR $0.64
  • Analyst Decision
  • GTE
  • NKTR Strong Buy
  • Analyst Count
  • GTE 0
  • NKTR 6
  • Target Price
  • GTE N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • GTE 275.9K
  • NKTR 2.8M
  • Earning Date
  • GTE 04-30-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • GTE N/A
  • NKTR N/A
  • EPS Growth
  • GTE N/A
  • NKTR N/A
  • EPS
  • GTE 0.10
  • NKTR N/A
  • Revenue
  • GTE $621,849,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • GTE $8.33
  • NKTR N/A
  • Revenue Next Year
  • GTE N/A
  • NKTR N/A
  • P/E Ratio
  • GTE $47.30
  • NKTR N/A
  • Revenue Growth
  • GTE N/A
  • NKTR 9.21
  • 52 Week Low
  • GTE $3.34
  • NKTR $0.43
  • 52 Week High
  • GTE $10.40
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • GTE 53.08
  • NKTR 45.85
  • Support Level
  • GTE $3.34
  • NKTR $0.43
  • Resistance Level
  • GTE $5.16
  • NKTR $0.68
  • Average True Range (ATR)
  • GTE 0.35
  • NKTR 0.08
  • MACD
  • GTE 0.04
  • NKTR 0.01
  • Stochastic Oscillator
  • GTE 76.37
  • NKTR 72.41

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: